|Cornell University, MBA||1998|
|BITS Pilani, BE and MS||1992|
|Engineering & Economics|
Anupendra Sharma is Partner at Siemens Venture Capital investing in healthcare (devices, diagnostics, software and services). He is currently an investor in China Diagnostics and Cylex and supports investments in Radpharm and U-Systems. He is a former investor in BioImagene (acquired by Roche) and Sequenom (NASD: SQNM).
Anupendra founded the Startup Leadership Program in Boston in 2006 to groom the next generation of startup CEOs, a global program in 12 cities for 500 entrepreneurs and innovators.
Prior to SVC, Anupendra was an investment banker and M&A professional for eight years at JPMorgan, Citigroup and Siemens, after he graduated from Cornellâ€™s MBA program. Prior to business school, Anupendra worked at Ford in the UK, and was a member of the team that set up Ford in both India and China.
Anupendra co-founded Mobile Medics, named the Most Innovative Social Venture of 2006 by the Global Social Venture Competition for attempting to solve the â€œlast-mileâ€ problem for global rural healthcare, which later became eSwasthya, owned by Piramal Healthcare and an HBS case study. Mobile Medics was subject of an hour-long documentary by Japan Broadcasting Corporation and a University of Toronto business school case. Anupendra also started a shrimp farm in Belize, Central America while at business school.
Anupendra holds an MBA from Cornell University, MS in Accounting & Finance from Manchester Business School, Masters in Economics and Bachelors in Instrumentation Engineering from BITS Pilani, India.